JOUNCE THERAPEUTICS INC's ticker is JNCE and the CUSIP is 481116101. A total of 85 filers reported holding JOUNCE THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.75 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $28 | +86.7% | 15,195 | +11.4% | 0.00% | – |
Q4 2022 | $15 | -100.0% | 13,635 | +1.0% | 0.00% | – |
Q3 2022 | $32,000 | -33.3% | 13,495 | -14.4% | 0.00% | -100.0% |
Q2 2022 | $48,000 | -72.4% | 15,768 | -32.6% | 0.00% | 0.0% |
Q3 2021 | $174,000 | +216.4% | 23,393 | +44.3% | 0.00% | – |
Q4 2018 | $55,000 | -81.3% | 16,213 | -29.7% | 0.00% | -100.0% |
Q4 2017 | $294,000 | – | 23,079 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TRV GP II, LLC | 2,697,829 | $20,045,000 | 88.84% |
TRV GP III, LLC | 3,048,780 | $22,652,000 | 4.30% |
Logos Global Management LP | 2,000,000 | $14,860,000 | 1.07% |
SILVERARC CAPITAL MANAGEMENT, LLC | 208,559 | $1,550,000 | 0.88% |
PFM Health Sciences, LP | 3,848,822 | $28,597,000 | 0.84% |
Yorktown Management & Research Co Inc | 113,200 | $841,000 | 0.63% |
Moloney Securities Asset Management, LLC | 282,250 | $2,097,000 | 0.38% |
PATHWAY CAPITAL MANAGEMENT, LP | 84,763 | $630,000 | 0.30% |
Sofinnova Investments, Inc. | 637,347 | $4,735,000 | 0.28% |
Omega Fund Management, LLC | 275,513 | $2,047,000 | 0.23% |